Clues was founded by Dr. Bingchu Deng, former CSO of Shanghai Hengrui Pharma, HEC Pharma, and Haisco Pharma in November 2018. Their focus is on the discovery of innovative small molecule drug that are either “First-in-class” or “best-in-class".